Joint DIA/MEB “Excellence in Pharmacovigilance” Module 2: Safety Aspects in Clinical Trials

Module 2 will provide the safety reporting requirements, the roles, and responsibilities of all stakeholders in clinical trials.

Continuing Education

The Swiss Association of Pharmaceutical Professionals (SwAPP) and the Swiss Society for Pharmaceutical Medicine (SGPM) have accredited this training course with 5.5 credits.
Special rates available for SwAPP and SGPM members.

Name	Credit Type	Max Credits	CEU
"Excellence in PV" Module 2, 11-12 Nov 2021, 08:30-13:00 CET, Virtual Event	Credit TypeSWAPP/SGPM	Max Credits5.50	CEU0.000

Statement of Credit:

All DIA training courses and meetings are accredited by the Swiss Association of Pharmaceutical Professionals (SwAPP) Commission for Professional Development (CPD) and Swiss Society of Pharmaceutical Medicine (SGPM).

Joint DIA/MEB “Excellence in Pharmacovigilance” Module 2: Safety Aspects in Clinical Trials

Continuing Education

Statement of Credit:

获得信息并保持参与